Control of bone mineralisation in osteoporosis
Osteoporosis is a major public health issue, and it has been estimated that total annual cost of osteoporosis/osteopenia in Australia is around $2,754 million.
Showing 181 - 200 of 376 results
Osteoporosis is a major public health issue, and it has been estimated that total annual cost of osteoporosis/osteopenia in Australia is around $2,754 million.
ANSTO provides trusted advice, training and consultancy services to Australia’s resource sector.
View the upcoming proposal deadlines for access to ANSTO’s Research Portal. The User Office provides support for research proposals and enables you to leverage our world-class research infrastructure and facilities.
In part 1 of this two-part series, ANSTO scientists from across the organisation became film critics to review Christopher Nolan’s new movie, Oppenheimer, which explores the life of the director of the Manhattan Project to develop an atomic weapon.
Ultra-flexible electronics has many potential applications within areas such as for example the military, healthcare and energy.
ANSTO has warmly welcomed the official launch of the Monash Precinct Network by Victorian Member for Ashwood, Matt Fregon MP at a special event at the Australian Synchrotron.
ANSTO’s CORIS360®, an advanced radiation imaging solution, has been awarded two Gold Good Design Awards from Good Design Australia, winning in the categories of Product Design/ Commercial and Industrial as well as Engineering Design.
Polarised neutron scattering on Sika instrument
ANSTO's reactor utilisation team has received an international award.
A specialist in particle therapy treatment planning from the Mayo Clinic in the US, Professor Chris Beltran, recently visited ANSTO for an exchange for information.
Research explores how structure contributes to function in food
ANSTO today welcomed a significant Federal Government funding allocation to further safeguard the production of life-saving nuclear medicines in Australia.
ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.
ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.
For over 40 years, ANSTO has provided consultancy and process development services to the mining and minerals processing industries in Australia and globally.
Industrial Engagement Manager at ANSTO and Professor in Advanced Structural Materials at the University of Sydney, Anna Paradowska is among the authors who contributed to a 2019 paper that was recently awarded the ASM International ASM Henry Marion Howe Medal in Metallurgical and Materials Transactions A.
Using the Australian Synchrotron, an international team of researchers has characterised an important interaction that helps the SARS-CoV-2 virus invade human cells.